Baptist Health Doc-to-Doc

Advanced Epilepsy Care: From Diagnosis to Brain Stimulation

Epilepsy care has evolved dramatically in recent years. Advances in diagnostics, surgical techniques, and neuromodulation are transforming how physicians treat patients with drug-resistant epilepsy. In this episode of Baptist Health Doc to Doc, Neurosurgeon and System Chief Executive of Baptist Health Brain & Spine Care and Chief Medical Executive of Miami Neuroscience Institute, Dr. Michael McDermott is joined by epilepsy experts, Dr. Aviva Abosch, deputy director of the Institute as well as director of epilepsy surgery and co-director of functional neurosurgery and Dr. Luis Tornes, neurologist and the director of the epilepsy program at the Miami Neuroscience Institute at Baptist Health South Florida. Together they explore how multidisciplinary teams diagnose epilepsy, evaluate patients for surgery, and use advanced technologies such as responsive neurostimulation, deep brain stimulation, and stereotactic EEG to improve outcomes. Topics include: ·         How physicians specialize in epilepsy care ·         The role of epilepsy monitoring units ·         Surgical approaches for drug-resistant epilepsy ·         Neuromodulation technologies like RNS, DBS, and VNS ·         Emerging therapies including biologics and cellular treatments This conversation offers a deeper look at how neuroscience innovation is improving quality of life for patients living with epilepsy. Learn more about the Epilepsy Program at Miami Neuroscience Institute:  baptisthealth.net/neuroscience [https://baptisthealth.net/services/brain-and-spine-care] Host: Michael McDermott, M.D. Neurosurgeon & Chief Medical Executive  Baptist Health Miami Neuroscience Institute Chair, Neurosciences, FIU Guests: Aviva Abosch, M.D. Neurosurgeon & Deputy Director  Baptist Health Miami Neuroscience Institute  Luis Tornes, M.D.  Neurologist & Director of the Epilepsy Program  Baptist Health Miami Neuroscience Institute If you found this episode helpful, you may also enjoy: The Pituitary Playbook - Functional Tumors, Vision Risks & Endoscopic Solutions [https://www.buzzsprout.com/1899075/episodes/17947134] Evolving Advances in Brain Tumor Care  [https://www.buzzsprout.com/1899075/episodes/17269209] TMS: Making Waves with Treatment Resistant Depression [https://www.buzzsprout.com/1899075/episodes/14502530]

Optimizing Women’s Cancer Care: AI, Robotics and Precision Medicine

In this episode of Baptist Health Doc to Doc, Dr. John Diaz and Dr. Mehran Habibi discuss how artificial intelligence, robotic surgery, precision medicine, and targeted therapies are transforming breast cancer and gynecologic oncology in 2026. Topics include: - AI-assisted breast imaging and surgical planning - Robotic hysterectomy and minimally invasive cancer surgery - De-escalation of sentinel lymph node biopsy - Circulating tumor DNA (MRD) and treatment personalization - Antibody-drug conjugates (ADCs) - Oral SERDs and evolving endocrine therapy - HPV vaccination and cervical cancer prevention As cancer care moves from radical procedures to optimized, personalized treatment, innovation is improving outcomes while reducing recovery time and surgical risk. Presenters: John P. Diaz, M.D., FACOG, FACS Chief of Gynecologic Oncology Baptist Health Miami Cancer Institute Mehran Habibi, M.D., MBA Deputy Chief of Breast Surgery Baptist Health Cancer Care

Advances in Radiation Oncology: What to know about Proton & Photon Therapy in 2026

Join Joseph Panoff, M.D., radiation oncologist at Baptist Health Miami Cancer Institute, and Youssef Zeidan, M.D., radiation oncologist at Lynn Cancer Institute, for an in-depth physician-to-physician discussion on modern breast cancer radiation therapy. They explore how photon-based radiation has evolved over the last two decades—from early planning techniques to today’s highly conformal approaches that improve precision while reducing toxicity. The conversation also examines emerging comparisons between proton and photon therapy, including how each modality impacts cardiac exposure, skin toxicity, and long-term survivorship considerations. This episode highlights the importance of individualized treatment planning, the growing focus on safely reducing unnecessary treatment, and how collaboration across leading cancer institutes is shaping the future of radiation oncology. Host: Joseph Panoff, M.D.   Radiation Oncologist Baptist Health Miami Cancer Institute Guest: Youssef Zeidan, M.D.   Radiation Oncologist Lynn Cancer Institute

Young Women & Breast Cancer: Understanding Early-Onset Risk, Genetics & Fertility

In this episode of Baptist Health’s Doc-to-Doc, we take a closer look at one of the most concerning trends in oncology — the rise of breast cancer among younger women. Dr. Anastasia Tousimis, Deputy Director of Baptist Health Cancer Care, sits down with Dr. Louise Morrell, Chief Medical Executive of Lynn Cancer Institute, to discuss what’s driving this gradual increase and how clinicians can better identify, screen and support high-risk patients. Together, they explore the latest research on environmental and genetic factors, screening challenges in dense breasts and how AI is transforming early detection. The discussion also highlights fertility preservation and the importance of multidisciplinary care for young women navigating a diagnosis. From radiation exposure to BRCA mutations, this conversation connects cutting-edge science with compassionate care — offering practical insight for clinicians and reassurance for patients alike. Host: Anastasia Tousimis, M.D. Deputy Director, Baptist Health Cancer Care Medical Director, Al and Jane Nahmad Women's Cancer Center, Baptist Health Expert: Louise Morrell, M.D. Chief Medical Executive Eugene M. & Christine E. Lynn Cancer Institute Baptist Health Boca Raton Regional Hospital

The Pituitary Playbook — Functional Tumors, Vision Risk & Endoscopic Solutions

In this Baptist Health Doc-to-Doc episode, Dr. Michael McDermott, Chief Medical Executive of Baptist Health Miami Neuroscience Institute sits down with Dr. Evan Bander, Neurosurgeon & Co-Director of  the Pituitary Tumor Program at the Baptist Health Miami Neuroscience Institue, to unpack the complexities of the body’s “master gland.”  Together, they explore how pituitary tumors are diagnosed and treated, the difference between functional and non-functional adenomas and why minimally invasive endoscopic surgery is changing outcomes. You’ll hear about early warning signs such as vision changes, the importance of a multidisciplinary pituitary team and the latest surgical and radiosurgical approaches. Whether you’re a clinician managing these conditions or a patient seeking to better understand them, this discussion sheds light on earlier detection, safer surgery and lifelong follow-up. 👉 If you are a neurosurgeon, endocrinologist, or ENT specialist managing pituitary disorders, this conversation will help sharpen your clinical edge. 👀 Patients and families can also learn what to look for and what today’s treatment options mean for long-term health. 🔔 Subscribe for more expert insights: @BaptistHealthSF Host: Michael McDermott, M.D. Chief Medical Executive and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience at Miami Neuroscience Institute, as well as Chair of the Department of Neurosciences at Florida International University Herbert Wertheim College of Medicine Expert: Evan Bander, M.D. Neurosurgeon & Co-Director of the Pituitary Tumor Program Baptist Health Miami Neuroscience Institute